Ayurvedic Management in Coronary Heart Disease

Clinical Evaluation of Pippalyadi Churna in the Management of Vataja Hridroga w s r to Coronary Artery Disease - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102460

Enrollment

Registered

2026-01-29

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Both male and female patients will be randomly selected without any bias of Social, Educational, Religious and Economic status 2 Patient previously diagnosed as IHD 3 Patient not willing for any kind of cardiac surgery . 4 Patient with mild to moderate chest pain 5 Mild to moderate Hypertension 6 Mild to moderate dyspnea 7 History of stable angina 8 Patient having palpitations 9 Patient with Diabetes Mellitus

Exclusion criteria

Exclusion criteria: 1 Patient below 30 yrs, and above 60 yrs. 2 Acute case of MI 3 Unstable Angina 4 Congenital Heart Disease, Vulvular Heart Disease 5 Endocarditis, Myocarditis, Pericarditis 6 Patient complaining chest pain without cardiac cause 7 Any type of Autoimmune disorder 8 Patients who are not willing to come under trial or give consent. 9 History of or presence of Type 1 DM 10 Presence of any other form of chronic liver disease, Kidney disease, Asthma. 11 History of any major surgery within six months. 12 Any malignant neoplasia. 13 Creatinine level more than 1.2 mg per dl and urea level more than 40 mg per dl. 14 Uncontrolled Type 2 DM 15 More than 90 percent blockage of coronary artery

Design outcomes

Primary

Measure	Time frame
1. To evaluate the effect of Pippalyadi churna as an adjuvant therapy with modern treatment protocol of Vataja Hridroga w.s.r. to CAD 2. To evaluate the effect of Pippalyadi churna in the management of Vataja Hridroga w.s.r to CADTimepoint: At baseline and after 2 weeks , 4 weeks, 6 weeks, 8 weeks	—

Secondary

Measure	Time frame
1. To study the vataja hridroga and correlate according to modern science. 2. To encourage the future worker of this field for better evaluation, proper implementation of safe and effective combined treatment protocol towards the problem of vataja hridroga.Timepoint: At baseline and after 2 weeks , 4 weeks, 6 weeks, 8 weeks	—

Countries

India

Contacts

Public ContactDr Tapas Bhaduri

Institute of post graduate ayurvedic education and research

dr.tapasbhaduri@gmail.com9836362763

Outcome results